Clinical Trial Update: Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 safety and tolerability comparison of azilsartan medoxomil with chlorthalidone versus olmesartan medoxomil with hydrochlorothiazide in participants with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BENICAR (OLMESARTAN MEDOXOMIL)
• Chlorthalidone (chlorthalidone)
• Edarbi (azilsartan medoxomil)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-11-12